Shaheed Suhrawardy Medical College Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2010
NCT01122771
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Shaheed Suhrawardy Medical College Hospital, Dhaka, Bangladesh

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leishmaniasis (Phase 3)

Leishmaniasis, Visceral (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3